
### [DOID:0050687](http://purl.obolibrary.org/obo/DOID_0050687)
**Label:** cell type cancer

**Subclasses:** [DOID:4450](http://purl.obolibrary.org/obo/DOID_4450) (renal cell carcinoma), [DOID:5363](http://purl.obolibrary.org/obo/DOID_5363) (myxoid liposarcoma), [DOID:3070](http://purl.obolibrary.org/obo/DOID_3070) (malignant glioma), [DOID:8923](http://purl.obolibrary.org/obo/DOID_8923) (skin melanoma), [DOID:6039](http://purl.obolibrary.org/obo/DOID_6039) (uveal melanoma), [DOID:3962](http://purl.obolibrary.org/obo/DOID_3962) (follicular thyroid carcinoma), [DOID:1790](http://purl.obolibrary.org/obo/DOID_1790) (malignant mesothelioma), [DOID:3347](http://purl.obolibrary.org/obo/DOID_3347) (osteosarcoma), [DOID:4440](http://purl.obolibrary.org/obo/DOID_4440) (seminoma), [DOID:5520](http://purl.obolibrary.org/obo/DOID_5520) (head and neck squamous cell carcinoma), [DOID:6126](http://purl.obolibrary.org/obo/DOID_6126) (anal canal carcinoma), [DOID:5409](http://purl.obolibrary.org/obo/DOID_5409) (lung small cell carcinoma), [DOID:684](http://purl.obolibrary.org/obo/DOID_684) (hepatocellular carcinoma), [DOID:3969](http://purl.obolibrary.org/obo/DOID_3969) (papillary thyroid carcinoma), [DOID:2513](http://purl.obolibrary.org/obo/DOID_2513) (basal cell carcinoma), [DOID:4905](http://purl.obolibrary.org/obo/DOID_4905) (pancreatic carcinoma), 

**Corr. equiv. classes:** [OMIM:105580](http://purl.obolibrary.org/obo/OMIM_105580), [OMIM:613061](http://purl.obolibrary.org/obo/OMIM_613061), [OMIM:613063](http://purl.obolibrary.org/obo/OMIM_613063), [OMIM:182280](http://purl.obolibrary.org/obo/OMIM_182280), [OMIM:613062](http://purl.obolibrary.org/obo/OMIM_613062), [OMIM:114550](http://purl.obolibrary.org/obo/OMIM_114550), [OMIM:155720](http://purl.obolibrary.org/obo/OMIM_155720), [OMIM:613488](http://purl.obolibrary.org/obo/OMIM_613488), [OMIM:606661](http://purl.obolibrary.org/obo/OMIM_606661), [OMIM:606660](http://purl.obolibrary.org/obo/OMIM_606660), [OMIM:273300](http://purl.obolibrary.org/obo/OMIM_273300), [OMIM:607248](http://purl.obolibrary.org/obo/OMIM_607248), [OMIM:156240](http://purl.obolibrary.org/obo/OMIM_156240), [OMIM:260350](http://purl.obolibrary.org/obo/OMIM_260350), [OMIM:188550](http://purl.obolibrary.org/obo/OMIM_188550), [OMIM:188470](http://purl.obolibrary.org/obo/OMIM_188470), [OMIM:137800](http://purl.obolibrary.org/obo/OMIM_137800) (glioma susceptibility 1), [OMIM:613030](http://purl.obolibrary.org/obo/OMIM_613030), [OMIM:613032](http://purl.obolibrary.org/obo/OMIM_613032), [OMIM:613031](http://purl.obolibrary.org/obo/OMIM_613031), [OMIM:300854](http://purl.obolibrary.org/obo/OMIM_300854), [OMIM:613033](http://purl.obolibrary.org/obo/OMIM_613033), [OMIM:612263](http://purl.obolibrary.org/obo/OMIM_612263), [OMIM:613058](http://purl.obolibrary.org/obo/OMIM_613058), [OMIM:613059](http://purl.obolibrary.org/obo/OMIM_613059), [OMIM:275355](http://purl.obolibrary.org/obo/OMIM_275355), [OMIM:605462](http://purl.obolibrary.org/obo/OMIM_605462), [OMIM:608035](http://purl.obolibrary.org/obo/OMIM_608035), [Orphanet:39044](http://www.orpha.net/ORDO/Orphanet_39044), [OMIM:259500](http://purl.obolibrary.org/obo/OMIM_259500), [Orphanet:182067](http://www.orpha.net/ORDO/Orphanet_182067), 

**Class expressions from DL-Learner:**

- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system))) 49.87%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 49.21%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 49.21%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 49.21%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 49.21%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 49.21%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 49.21%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 49.21%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 49.21%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 48.31%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 44.10%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 42.93%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 35.58%
- Thing 35.53%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 35.53%


